Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 188.71 | 167.61 | 163.03 | 90.06 |
Total Revenue | 188.71 | 167.61 | 163.03 | 90.06 |
Costof Revenue Total | 102.81 | 89.64 | 89.64 | 41.76 |
Gross Profit | 85.90 | 77.96 | 73.39 | 48.30 |
Selling/ General/ Admin Expenses Total | 23.72 | 54.72 | 17.43 | 13.68 |
Depreciation/ Amortization | 6.96 | 6.53 | 5.87 | 5.16 |
Other Operating Expenses Total | 38.63 | 0.18 | 32.93 | 24.67 |
Total Operating Expense | 172.13 | 151.13 | 145.87 | 85.27 |
Operating Income | 16.58 | 16.48 | 17.16 | 4.79 |
Interest Inc( Exp) Net- Non- Op Total | -53.46 | -42.40 | -47.94 | -48.34 |
Other Net | 0.82 | 0.03 | -0.11 | -0.04 |
Net Income Before Taxes | 12.05 | 12.28 | 12.26 | -0.08 |
Provisionfor Income Taxes | 2.42 | 3.65 | 4.01 | 0.28 |
Net Income After Taxes | 9.62 | 8.63 | 8.26 | -0.36 |
Minority Interest | -0.02 | -0.01 | -0.02 | 0.00 |
Net Income Before Extra Items | 9.61 | 8.62 | 8.24 | -0.36 |
Net Income | 9.61 | 8.62 | 8.24 | -0.36 |
Income Availableto Com Excl Extra Ord | 9.61 | 8.62 | 8.24 | -0.36 |
Income Availableto Com Incl Extra Ord | 9.61 | 8.62 | 8.24 | -0.36 |
Diluted Net Income | 9.61 | 8.62 | 8.24 | -0.36 |
Diluted Weighted Average Shares | 1.15 | 1.11 | 0.85 | 0.85 |
Diluted EPS Excluding Extra Ord Items | 8.38 | 7.79 | 9.68 | -0.43 |
Diluted Normalized EPS | 8.38 | 7.82 | 9.68 | -0.43 |
Unusual Expense( Income) | - | 0.06 | - | - |
Gain( Loss)on Saleof Assets | - | 0.12 | 0.03 | 0.00 |
Parnax Lab Dividend Parnax Lab Bonus Parnax Lab News Parnax Lab AGM Parnax Lab Rights Parnax Lab Splits Parnax Lab Board Meetings Parnax Lab Key Metrics Parnax Lab Shareholdings Parnax Lab Balance Sheet Parnax Lab Cashflow Parnax Lab Q1 Results Parnax Lab Q2 Results Parnax Lab Q3 Results Parnax Lab Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks